Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with agonist tigatuzumab in an orthotopic mouse model
Titel:
Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with agonist tigatuzumab in an orthotopic mouse model
Auteur:
Yamamoto, Jun Miyake, Kentaro Han, Qinghong Tan, Yuying Inubushi, Sachiko Sugisawa, Norihiko Higuchi, Takashi Tashiro, Yoshihiko Nishino, Hiroto Homma, Yuki Matsuyama, Ryusei Chawla, Sant P. Bouvet, Michael Singh, Shree Ram Endo, Itaru Hoffman, Robert M.